Skip to Main Content

The future of addiction therapy could soon look a lot like treatment for diabetes.

A California-based addiction treatment company hopes to change the way patients struggling with substance abuse disorder receive a popular form of medication-assisted treatment. If approved, patients could self-administer naltrexone, an opioid antagonist, in the comfort of their own homes — like insulin, but for recovering addicts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • Because off danger of precipitating an acute withdrawal reaction giving naltrexone to an active opiate user this should only be done in a medical setting. But hey, california dope fiends get “kicks” from your grand mal seizure if you want.

Comments are closed.